Availability
0
Your Basket is Empty
BA17967

ACPA

Agonist of cannabinoid receptors. Inhibits forskolin-induced cAMP release from human CB1-transfected Chinese hamster ovary (CHO) cells by enhancing the binding of [35S]GTPγS to cerebellar membrane. Although initially identified as a CB1-selective agonist, ACPA inhibits migration of BV-2 cells, demonstrating its action on CB2 receptors. 

Technical Data

CAS No: 229021-64-1
Synonyms: (5Z,8Z,11Z,14Z)-N-Cyclopropyl-5,8,11,14-eicosatetraenamide; Arachidonylcyclopropylamide
Product Code: BA17967
MDL No: MFCD02683582
Chemical Formula: C23H37NO
Molecular Weight: 343.55

References


  • Hillard CJ et al (1999). Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1). J Pharmacol Exp Ther 289(3):1427-33.
  • Franklin A and Stella N (2003). Arachidonylcyclopropylamide increases microglial cell migration through cannabinoid CB2 and abnormal-cannabidiol-sensitive receptors. Eur J Pharmacol 474(2-3):195-8.

Solubility

Stability

Further Information


Datasheets


CAS No:
229021-64-1
Synonyms:
(5Z,8Z,11Z,14Z)-N-Cyclopropyl-5,8,11,14-eicosatetraenamide
Arachidonylcyclopropylamide
MDL No:
MFCD02683582
Chemical Formula:
Molecular Weight:
343.55
Product Structure
References:
1. Hillard CJ et al (1999). Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1). J Pharmacol Exp Ther 289(3):1427-33.
2. Franklin A and Stella N (2003). Arachidonylcyclopropylamide increases microglial cell migration through cannabinoid CB2 and abnormal-cannabidiol-sensitive receptors. Eur J Pharmacol 474(2-3):195-8.

For requirements greater than the catalogue prepacks email: enquiries@carbosynth.com

Custom Synthesis

For custom synthesis or special requests email: enquiries@carbosynth.com, call +44 (0)1635 578444 or fill out our contact form

Please Wait...